Thanks for this,
@jamesc666. The price has swung to extreme deep value and despondency.
The IP is backed by 200 Aspiral plants installed in China and ROW. They are guiding at least growth of 60% in SPS this year to US$32m.
Please see the updates. China operations are employing new engineers as you posted earlier
here. Aspiral Micro has been launched in
Shanghai, a customer led design that the boffins in Israel responded to. As we know, six months following a launch will lead to bulk orders as happened with iTest and Kaitian.
I feel like a broken record.
(20min delay)